Literature DB >> 16680223

Auditory symptoms in whiplash patients - could earwax occlusion be a benign cause?

Robert Ferrari1.   

Abstract

BACKGROUND: Excess cerumen (earwax) in the external auditory canal is associated with symptoms of earache, fullness in the ears, and diminished hearing. These symptoms, and tinnitus, are commonly associated with whiplash injury.
METHODS: Eighty-six whiplash patients were examined to determine if there was a correlation between symptoms of earache, fullness in the ear, diminished hearing, and tinnitus, and the degree of cerumen occlusion. Cerumen occlusion was measured by visualisation of the tympanic membrane and graded according to a 4 point scale.
RESULTS: Of 71 subjects reporting no acute onset (within 7 days of the collision that caused their whiplash) earache, fullness in the ears, hearing loss, or tinnitus, 62 had little or no cerenum occlusion. Of seven subjects reporting tinnitus but no other auditory symptoms, none had greater than moderate cerenum occlusion. Of eight subjects reporting one or more of acute onset earache, fullness in the ears, diminished hearing, and tinnitus, seven had complete cerenum occlusion in the affected ear. DISCUSSION: The findings suggest high grade cerumen occlusion frequently occurs in the ear affected by acute auditory symptoms. However, tinnitus alone has no apparent association with cerumen occlusion. It is possible that a significant number of acute onset auditory symptoms reported in whiplash patients have a benign cause.

Entities:  

Mesh:

Year:  2006        PMID: 16680223

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  2 in total

Review 1.  Practice-audit-publish: A practice reflection.

Authors:  Robert Ferrari
Journal:  Eur J Rheumatol       Date:  2016-01-29

2.  Vestibular and stabilometric findings in whiplash injury and minor head trauma.

Authors:  A Nacci; M Ferrazzi; S Berrettini; E Panicucci; J Matteucci; L Bruschini; F Ursino; B Fattori
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-12       Impact factor: 2.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.